Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Haplotype of the BRCA2 6857delAA mutation in 4 families with breast/ovarian cancer].

Medicina clinica - 23 Oct 2004

Campos Berta, Díez Orland, Alvarez Carolina, Palma Lorena, Domènech Montserrat, Balmaña Judith, Sanz Judit, Ramírez Amaya, Alonso Carmen, Carvallo Pilar, Baiget Montserrat

Abstract excerpt

BACKGROUND AND OBJECTIVE: It is estimated that 5-10% of all breast cancers are hereditary, mainly are due to germline mutations in the BRCA1 and BRCA2 genes. PATIENTS AND METHOD: A BRCA2 screening was carried out in familial breast/ovarian cancer at two centres in Spain and Chile. The 6857delAA m...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Chile
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Haplotypes

Share to Microsatellite Repeats

Share to Ovarian Neoplasms

Share to Pedigree

Source

Identifiers

PMID: 15535929
DOI: 10.1016/s0025-7753(04)74590-x

Genes

BRCA2
BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15535929-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Haplotype of the BRCA2 6857delAA mutation in 4 families with breast/ovarian cancer].PMID 15535929Read ↗

Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families from Spain.Semantic proximity Read ↗

BRCA1 5272-1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin.Semantic proximity Read ↗

[BRCA1 and BRCA2 mutations in families studied in the program of genetic counselling in cancer of the Valencian community (Spain)].Semantic proximity Read ↗

The deletion of exons 3-5 of BRCA1 is the first founder rearrangement identified in breast and/or ovarian cancer Spanish families.Semantic proximity Read ↗

Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.Semantic proximity Read ↗

Two founder BRCA2 mutations predispose to breast cancer in young women.Semantic proximity Read ↗

Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.Semantic proximity Read ↗

Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain.Semantic proximity Read ↗

Segregation analysis of the BRCA2 c.9227G>T variant in multiple families suggests a pathogenic role in breast and ovarian cancer predisposition.Semantic proximity Read ↗

Molecular analysis of the BRCA2 gene in 16 breast/ovarian cancer Spanish families.Semantic proximity Read ↗

Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes.Semantic proximity Read ↗

Novel BRCA1 deleterious mutation (c.1918C>T) in familial breast and ovarian cancer syndrome who share a common ancestry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.